Blood C-reactive protein concentration with ABCD is a better prognostic tool than ABCD 2 alone

Cerebrovascular Diseases

Volumn 32, Issue 2, 2011, Pages 97-105

  Corso, Giovanni ^a   Bottacchi, Edo ^a   Brusa, Adriana ^a   Lia, Chiara ^a   Cordera, Susanna ^a   Giardini, Guido ^a   Pesenti Campagnoni, Massimo ^a   Veronese Morosini, Massimo ^a  

^a Ospedale Regionale   (Italy)

Author keywords

Blood proteins; Cardiovascular diagnostic technique; Stroke; Transient ischaemic attack

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; HIGH RISK PATIENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MODEL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, STATISTICAL; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE;

EID: 79959544636     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000328230     Document Type: Article

References (33)

1. Coull AJ, Lovett JK, Rothwell PM: Population based study of early risk of stroke after transient ischemic attack or minor stroke: Implication for public education and organisation of services. BMJ 2004; 328: 326.9
2. Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP: The high risk of stroke immediately after transient ischemic attack: A population-based study. Neurology 2004; 62: 2015-2020. (Pubitemid 38738214)
3. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G: C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet 2009; 375: 132-140.
4. Ridker PM, Cook N: Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 2004; 109: 1955-1959. (Pubitemid 38544485)
5. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR: C-reactive protein and outcome after ischemic stroke. Stroke 1999; 30: 981-985. (Pubitemid 29211614)
6. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, Emsley HCA, Forconi S, Hopkins SJ, Masotti L, Muir KW, Paciucci A, Papa F, Roncacci S, Sander D, Smig CJ, Stefanini A, Weber D: Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke. Stroke 2005; 36: 1316-1329.
7. Arenillas JF, Alvarez-Sabin J, Molina CA, Chacon P, Montaner J, Rovira A, Ibarra B, Quintana M: C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003; 34: 2463-2470.
8. Cucchiara LB, Messe SR, Sansing L, Mac-Kenzie L, Taylor RA, Pacelli J, Shah Q, Kasner SE: Lipoprotein-associated phospholipase A 2 and C-reactive protein for risk-stratification of patient with TIA. Stroke 2009; 40: 2332-2336.
9. Purroy F, Montaner J, Molina CA, Delgado P, Arenillas JF, Chacon P, Quintana M, Alvares-Sabin J: C-reactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurol Scand 2007; 115: 60-66. (Pubitemid 44915500)
10. Rothwell PM, Warlow CP: Timing of transient ischaemic attacks preceding ischaemic stroke. Neurology 2005; 64: 817-820.
11. Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, Sidney S: Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369: 283-292. (Pubitemid 46136488)
12. Easton JD, Saver JL, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, Johnston SC, Kidwell CS, Lutsep HL, Miller E, Sacco RL: Definition and evaluation of transient ischemic attack: A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke 2009; 40: 2276-2293.
13. NICE Clinical Guideline 68: Stroke: Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA). www. nice,org,uk/CG068 (accessed January 2010).
14. Corso G, Bottacchi E, Giardini G, De la Pierre F, Meloni T, Pesenti Compagnoni M, Ponzetti C, Veronese Morosini M: Community-based study of stroke incidence in the Valley of Aosta, Italy. Neuroepidemiology 2009; 32: 186-195.
15. Albers GW, Caplan LR, Easton JD, et al, TIA Working Group: Transient ischaemic attack: Proposal for a new definition. N Engl J Med 2002; 347: 1713-1716. (Pubitemid 35340795)
16. Hatano S: Experience from a multicentre stroke register: A preliminary report. Bull World Health Organ 1976; 54: 541-553. (Pubitemid 8114220)
17. Grant EG, Benson CB, Moneta GI, Alexandrov AV, Baker JD, Bluth EI, Carroll BA, Eliasziw M, Gocke J, Hertzberg BS, Katanick S, Needleman L, Pellerito J, Polak JF, Rholl KS, Wooster DL, Zierler RE: Carotid artery stenosis: Gray-scale and Doppler US diagnosis -Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003; 229: 340-346. (Pubitemid 37310815)
18. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44: 837-845.
19. Pencina MJ, D'Agostino RB, D'Agostino RB Jr, Vasan RS: Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172. (Pubitemid 351193639)
20. Vickers AJ, Elkin EB: Decision curve analysis: A novel method for evaluating prediction models. Med Decision Making 2006; 26: 565-574. (Pubitemid 44728772)
21. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F: Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease controls and prevention and the American Heart Association. Circulation 2003; 107: 499-511. (Pubitemid 36158056)
22. Pasceri V, Cheng JS, Willerson JT, Yet ET, Chang J: Modulation of C-reactive proteinmediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001; 103: 2531-2534. (Pubitemid 32521959)
23. Arenillas JF, Massot A, Sabín J-A, Cadenas I-F, del Rio-Espinola A, Chacon P, Quintana M, Molina CA, Rovina A, Montaner J: C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses. Cerebrovasc Dis 2009; 28: 95-102.
24. Wu CM, McLaughlink K, Lorenzetti DL, Hill MD, Mamis BJ, Ghali WA: Early risk of stroke after TIA: Systemic review and metaanalysis. Arch Intern Med 2007; 167: 2417-2422. (Pubitemid 350258447)
25. Merwick A, Albers GW, Amarenco P, Arsava EM, Ay H, Calvet D, Coutts SB, Cucchiara BL, Demchuk AM, Furie KI, Giles MF, Labreuche J, Lavallée PC, Mas JL, Olivot JM, Purroy F, Rotwell PM, Saver JL, Sheehan OC, Stack JP, Walsh C, Kelly PJ: Addition of brain and carotid imaging to the ABCD 2 score to identify patients at early risk of stroke after transient ischaemic attack: A multicentre observational study. Lancet Neurol 2010; 9: 1060-1069.
26. Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, Lovelock CE, Binney LE, Bull LM, Cuthbertson FC, Welch SJ, Bosch S, Carasco-Alexander F, Silver LE, Gutnikov SA, Metha Z: Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): A prospective population-based sequential comparison. Lancet 2007; 370: 1432-1442. (Pubitemid 47576154)
27. Baigent C, Keech A, Kearney PM, et al: Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.
28. Amarenco P, Bogousslavsky J, Callahan A, et al: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549-559. (Pubitemid 44202151)
29. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, et al: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.
30. Kennon S, Price CP, Mills PG, et al: The effect of aspirin on C-reactive protein as a marker of risk in unstable angina. J Am Coll Cardiol 2001; 37: 1266-1270.
31. Di Napoli M, Papa F: Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first ever ischemic stroke. Stroke 2003; 34: 2922-2929. (Pubitemid 37517770)
32. Shantikumar S, Grant PJ, Catto AJ, Bamford JM, Carter AM: Elevated C-reactive protein and long-term mortality after ischemic stroke. Relationship with markers of endothelial cell and platelet activation. Stroke 2009; 40: 977-979.
33. Okita K, Nishijma H, Murakami T, et al: Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol 2004; 24: 1868-1873. (Pubitemid 39350305)